Lineage Cell Therapeutics, Inc. Quarterly Cost of Revenue in USD from Q2 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Lineage Cell Therapeutics, Inc. quarterly/annual Cost of Revenue history and growth rate from Q2 2011 to Q3 2024.
  • Lineage Cell Therapeutics, Inc. Cost of Revenue for the quarter ending September 30, 2024 was $38K, a 77.5% decline year-over-year.
  • Lineage Cell Therapeutics, Inc. Cost of Revenue for the twelve months ending September 30, 2024 was $436K, a 15.7% decline year-over-year.
  • Lineage Cell Therapeutics, Inc. annual Cost of Revenue for 2023 was $671K, a 7.83% decline from 2022.
  • Lineage Cell Therapeutics, Inc. annual Cost of Revenue for 2022 was $728K, a 48.9% decline from 2021.
  • Lineage Cell Therapeutics, Inc. annual Cost of Revenue for 2021 was $1.43M, a 270% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $436K $38K -$131K -77.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $567K $44K -$83K -65.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $650K $98K -$21K -17.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $671K $256K +$154K +151% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 $517K $169K -$66K -28.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $583K $127K -$88K -40.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $671K $119K -$57K -32.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $728K $102K -$102K -50% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 $830K $235K -$750K -76.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $1.58M $215K +$90K +72% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $1.49M $176K +$64K +57.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $1.43M $204K +$90K +78.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 $1.34M $985K +$883K +866% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $453K $125K +$50K +66.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $403K $112K +$18K +19.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $385K $114K -$9K -7.32% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-10
Q3 2020 $394K $102K -$12K -10.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $406K $75K -$32K -29.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $438K $94K +$26K +38.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $412K $123K +$71K +137% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 $341K $114K +$79K +226% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $262K $107K +$1K +0.94% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $261K $68K -$41K -37.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $302K $52K -$2K -3.7% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 $304K $35K -$17K -32.7% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $321K $106K +$101K +2020% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $220K $109K +$52K +91.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $168K $54K +$74K Oct 1, 2017 Dec 31, 2017 10-K 2019-03-14
Q3 2017 $94K $52K -$6K -10.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $100K $5K -$90K -94.7% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 $190K $57K -$168K -74.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $358K -$20K -$171K -113% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-15
Q3 2016 $529K $58K -$374K -86.6% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $903K $95K -$165K -63.5% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $1.07M $225K -$39K -14.8% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $1.11M $151K -$71.1K -32% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-15
Q3 2015 $1.18M $432K +$201K +87% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 $977K $260K +$8K +3.18% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $969K $264K +$132K +100% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $837K $222K -$676 -0.3% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-16
Q3 2014 $838K $231K +$24.3K +11.8% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $813K $252K +$71.2K +39.4% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 $742K $132K -$50.8K -27.8% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 $793K $223K +$62.4K +38.9% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-15
Q3 2013 $731K $207K +$36.9K +21.8% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 $694K $181K +$96.9K +115% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-11
Q1 2013 $597K $183K +$162K +802% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 $434K $160K Oct 1, 2012 Dec 31, 2012 10-K 2015-03-11
Q3 2012 $170K +$151K +817% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $83.9K +$59.1K +238% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 $20.3K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q3 2011 $18.5K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 $24.8K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.